Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP497128.RABR-FjoU5sPQTwuwimdEFc6c3YRL3yJzYxZvly59-LcA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP497128.RABR-FjoU5sPQTwuwimdEFc6c3YRL3yJzYxZvly59-LcA130_assertion type Assertion NP497128.RABR-FjoU5sPQTwuwimdEFc6c3YRL3yJzYxZvly59-LcA130_head.
- NP497128.RABR-FjoU5sPQTwuwimdEFc6c3YRL3yJzYxZvly59-LcA130_assertion description "[As the acetylation status of histones has been linked to transcriptional regulation of genes involved particularly in differentiation and apoptosis, DAC inhibitors (DACi) have attracted considerable attention for treatment of hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497128.RABR-FjoU5sPQTwuwimdEFc6c3YRL3yJzYxZvly59-LcA130_provenance.
- NP497128.RABR-FjoU5sPQTwuwimdEFc6c3YRL3yJzYxZvly59-LcA130_assertion evidence source_evidence_literature NP497128.RABR-FjoU5sPQTwuwimdEFc6c3YRL3yJzYxZvly59-LcA130_provenance.
- NP497128.RABR-FjoU5sPQTwuwimdEFc6c3YRL3yJzYxZvly59-LcA130_assertion SIO_000772 21153858 NP497128.RABR-FjoU5sPQTwuwimdEFc6c3YRL3yJzYxZvly59-LcA130_provenance.
- NP497128.RABR-FjoU5sPQTwuwimdEFc6c3YRL3yJzYxZvly59-LcA130_assertion wasDerivedFrom befree-20140225 NP497128.RABR-FjoU5sPQTwuwimdEFc6c3YRL3yJzYxZvly59-LcA130_provenance.
- NP497128.RABR-FjoU5sPQTwuwimdEFc6c3YRL3yJzYxZvly59-LcA130_assertion wasGeneratedBy ECO_0000203 NP497128.RABR-FjoU5sPQTwuwimdEFc6c3YRL3yJzYxZvly59-LcA130_provenance.